Rajat Thawani

19PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 11, 2026
Updates in the Management of EGFR-Mutated Non-small Cell Lung Cancer (NSCLC).

Abhinav Vyas, Won Jin Jeon, Sanad Alhushki

|Mar 14, 2026
Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies.

Daniel Thomas Jones, Rishi Kumar Nanda, Abbas Ali Hussain

|Aug 28, 2025
Clinically Explainable Prediction of Immunotherapy Response Integrating Radiomics and Clinico-Pathological Information in Non-Small Cell Lung Cancer.

Jhimli Mitra, Soumya Ghose, Rajat Thawani

|Mar 13, 2025
Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives.

Sulin Wu, Rajat Thawani

|Aug 08, 2024
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

Rajat Thawani, Matteo Repetto, Clare Keddy

|May 17, 2024
Survival in metastatic microsatellite-stable colorectal cancer correlated with tumor mutation burden and mutations identified by next-generation sequencing.

Nicholas Taflin, Lyndsey Sandow, Rajat Thawani

Pageof 4

Frequent Collaborators

3 joint publications

Niha Beig

3 joint publications

Anant Madabhushi

2 joint publications

Alexander Drilon

2 joint publications

Catherine Z Beach